Sign inJoin waitlistJoin the waitlist

Corbin Eule

Clinical Member · University of Colorado School of Medicine

Credentials: · · · ·

History

University of Colorado School of Medicine
Present

University of Texas Southwestern Medical Center
2020–2022
Internal Medicine
University of Texas Southwestern Medical Center
2017–2020
University of Florida College of Medicine
2013–2017

Research

Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study
Clinical Genitourinary Cancer · 2023 · First of 14 authors · 19 citations
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
Seminars in Urologic Oncology · 2024 · First of 6 authors · 9 citations
Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen
Systematic review or meta-analysis · Urology · 2024 · First of 6 authors · 8 citations

Thomas Flaig
8 papers
Elaine Lam
6 papers
Simon Kim
4 papers
Tyler Robin
4 papers
Arjun Gupta
3 papers · 3 as a fellow
Boris Gershman
3 papers
Elizabeth Kessler
3 papers
Eryn Callihan
3 papers
Navid Sadeghi
3 papers
Alkesh Jani
2 papers
HL
Hsiao-Ching Li
2 papers
NC
Nellowe Candelario
2 papers · 1 as a fellow

Clinical trials

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Site PI · Recruiting · Phase 2
NRG Oncology
2023–2033
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Sub-investigator · Recruiting · Phase 2
University of Colorado, Denver
2023–2029
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
Sub-investigator · Recruiting · Early phase 1
University of Colorado, Denver
2022–2036